247 related articles for article (PubMed ID: 3289433)
1. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
[TBL] [Abstract][Full Text] [Related]
3. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
[TBL] [Abstract][Full Text] [Related]
4. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
[TBL] [Abstract][Full Text] [Related]
5. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
Perez V; Tanno H; Villamil F; Fay O
J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
[TBL] [Abstract][Full Text] [Related]
6. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
[TBL] [Abstract][Full Text] [Related]
8. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of steroid withdrawal followed by oral acyclovir in the treatment of chronic type B hepatitis.
Minuk GY; German GB; Bernstein C; Benarroch A; Gauthier T; Sekla L
Clin Invest Med; 1992 Dec; 15(6):506-12. PubMed ID: 1286532
[TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
Hoofnagle JH; Peters M; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Hallahan C; Park Y; Meschievitz C; Jones EA
Gastroenterology; 1988 Nov; 95(5):1318-25. PubMed ID: 3049216
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
Perez V; Findor J; Tanno H; Sordá J
Gut; 1993; 34(2 Suppl):S91-4. PubMed ID: 8314497
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
13. Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver.
Lok AS; Ma OC; Lau JY
Gastroenterology; 1991 Mar; 100(3):756-61. PubMed ID: 1993497
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
Fei GZ; Sylvan SP; Hellström UB; Yao GB
J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
16. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
[TBL] [Abstract][Full Text] [Related]
20. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
